Avandia is a medication that has been used for the treatment of Type 2 diabetes. For many patients, it was considered an important aid in helping to fight the negative effects of Type 2 diabetes. However, new research has suggested that it may not have substantial benefits for those who suffer from this condition. Moreover, it has been linked to the development of a number of serious or even life-threatening health conditions among users. For this reason, a growing number of people have taken legal action against Avandia’s manufacturer, GlaxoSmithKline, in order to recover compensation for the damages they have suffered.
Avandia Side Effects
Avandia has been linked to a range of troubling side effects, some of which may even place the lives of Avandia users in danger. Some of the most common of these side effects include the following:
- Heart attack
- Congestive heart failure
- Liver failure
- Bone fractures
- Eye damage
These are just some of the adverse side effects that Avandia users may experience. At the National Injury Law Center, our team of experienced lawyers understands just how much of a struggle it can be for injury victims to recover from these types of side effects. That’s why we make every effort to help those struggling with these effects to secure the compensation they need to be able to effectively deal with their losses.
The active ingredient in Avandia is rosiglitazone maleate, a type of thiazolidinedione that acts to make cells more responsive to insulin. There are also a number of inactive ingredients contained in the drug, including the following:
- Hypromellose 2910
- lactose monohydrate
- magnesium stearate
- microcrystalline cellulose
- polyethylene glycol 3000
- sodium starch glycolate
- titanium dioxide
In addition, individual dosages may contain different dyes to provide a distinctive coloration.
Get Help Today
Few things in life can be as difficult to cope with as the consequences of harmful pharmaceutical usage. Fortunately, those who have been injured or made ill because of pharmaceutical side effects are often entitled to pursue compensation for the damages they have suffered. However, in these circumstances, it is important to take action as soon as possible, as statutes of limitations place strict limits on the amount of time available for injury victims to pursue compensation.
At the National Injury Law Center, our legal team understands how important it is to help our clients fight for the financial compensation they desperately need to deal with the costs that can arise from a pharmaceutical side effect. That’s why we work tirelessly to help victims of dangerous drugs such as Avandia to pursue legal action to address their needs. Contact us today at 888-273-6041 to speak with a member of our legal team and learn more about what we can do for you.
Avandia and the FDA
Avandia was first approved by the U.S. Food and Drug Administration (FDA) in 1999 for the treatment of Type 2 diabetes. It soon became one of the more popular diabetes treatments available to patients. However, a study published in the New England Journal of Medicine in 2007 drew serious concerns regarding Avandia’s potential impact on patient health. The study suggested that Avandia could significantly increase the likelihood of suffering a heart attack for patients.
In light of this study, the FDA first issued a warning of ongoing safety reviews of Avandia to physicians in 2007. It also required labeling revisions to Avandia in order to make this risk more clear to patients. In 2009, the FDA released information also indicating that liver failure may be connected to the use of Avandia.
In 2010, the FDA began to substantially restrict access to Avandia, and in 2011, the agency instituted the Risk Evaluation and Mitigation Strategy (REMS) to regulate the drug. This program required patients to be prescribed Avandia by a qualified physician only after a determination had been made that no other medication could effectively help manage their blood sugar levels. In addition, the agency determined that the medication should no longer be available through retail pharmacies following November 18th, 2011. In late 2013, the FDA removed some of these restrictions.
History of Avandia
Avandia is part of a class of pharmaceuticals known as thiazolidinediones, which have been shown to have positive effects in helping patients suffering from Type 2 diabetes to cope with the effects of their condition. Avandia was first introduced by GlaxoSmithKline in 1999, and quickly became an extraordinarily popular pharmaceutical product, with sales over $2 billion in 2006 alone. However, in 2007, when reports came to light that Avandia might pose an increased risk of heart attacks for users, sales of the drug began to plummet.
After this initial report, evidence began to come to light that GlaxoSmithKline had intimidated doctors who had criticized the drug, withheld evidence showing a possible link between Avandia and heart illness, and engaged in deceptive marketing of the drug. In 2012, GlaxoSmithKline agreed to a $3 billion settlement with the United States Department of Justice, partially as a result of its decision to withhold the results of two studies showing a link between Avandia and cardiac arrest.
In 2012, GlaxoSmithKline’s patent for Avandia expired, and the first generic versions of the drug began to appear on the market. By that point, yearly sales of Avandia had dropped to only $9.5 million.
If you have been the victim of any of Avandia’s negative side effects, you may have a case to pursue legal action against the manufacturer of this harmful product. Contact the lawyers of the National Injury Law Center today by calling 888-273-6041 to speak with a qualified legal professional about the details of your experience and learn more about what we can do to help you take on the pharmaceutical company responsible for your needless suffering.